Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlethora Solutions Holdings Plc Regulatory News (PLE)

  • There is currently no data for PLE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Suspension of trading of Shares

7 Mar 2016 13:36

RNS Number : 2858R
Plethora Solutions Holdings PLC
07 March 2016
 

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. 

 

 

Recommended acquisition of Plethora Solutions Holdings plc ("Plethora")

by

Regent Pacific Group Limited ("Regent Pacific")

to be effected by means of a Scheme of Arrangement

under Part 26 of the Companies Act 2006 ("Scheme")

 

7 March 2016

Suspension of trading of Plethora Shares on AIM

Plethora announces that, with effect from 7.30 a.m. (London time) on 8 March 2016, trading in Plethora Shares on AIM will be suspended. The suspension is made pursuant to Plethora's application to the London Stock Exchange, as announced on 11 February 2016, and is effected in connection with the Scheme.

 

The Scheme remains conditional on, inter alia, Court approval being obtained at the Scheme Court Hearing which is scheduled to take place on 8 March 2016. The Scheme will become Effective once the Scheme Court Order has been delivered to the Registrar of Companies which is expected to take place on 9 March 2016.

 

Accordingly, following the application by Plethora to the London Stock Exchange, the cancellation of admission to trading of Plethora Shares on AIM will occur at 8.00 a.m. (London time) on 11 March 2016.

Full details of the Acquisition are set out in the scheme document dated 4 February 2016 sent to or made available to Plethora Shareholders (the "Scheme Document"). Except as otherwise defined herein, capitalised terms used but not defined in this announcement have the same meanings as given to them in the Scheme Document.

If any of the key dates set out in the expected timetable change, Plethora will give notice of this change by issuing an announcement through a Regulatory Information Service. Such announcement will, subject to certain restrictions, be made available on Plethora's website at www.plethorasolutions.co.uk and on Regent Pacific's website at www.regentpac.com respectively.

Enquiries:

 

 

Plethora

Michael G Wyllie, Chief Scientific Officer

 

Tel: +44 203 077 5400

Herax Partners LLP (Rule 3 Financial Adviser to Plethora)

John Mellett

Angus MacPherson

 

 

Tel: +44 207 399 1680

 

finnCap (Plethora Nomad and Broker)

Geoff Nash

Grant Bergman

 

Tel: +44 207 220 0500

(Corporate Finance)

Citigate Dewe Rogerson (Communications Adviser to Plethora)

 

David Dible

Sylvie Berrebi

 

Tel: +44 207 638 9571

 

This announcement is for information purposes only. It is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities whether pursuant to this announcement or otherwise.

Herax Partners LLP, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for Plethora and no one else in connection with the Acquisition and will not be responsible to anyone other than Plethora for providing the protections afforded to clients of Herax Partners LLP or for providing advice in connection with the Acquisition, the content of this announcement or any matter or arrangement referred to herein. Neither Herax Partners LLP nor any of its subsidiaries, branches or affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Herax Partners LLP in connection with this announcement, any statement contained herein or otherwise.

Overseas Plethora Shareholders

The distribution of this announcement in jurisdictions outside the United Kingdom and Hong Kong may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

The Acquisition relates to shares of a UK company and is proposed to be effected by means of a scheme of arrangement under the laws of England and Wales. A transaction effected by means of a scheme of arrangement is not subject to proxy solicitation or tender offer rules under the US Exchange Act. Accordingly, the Scheme is subject to the disclosure requirements, rules and practices applicable in the United Kingdom to schemes of arrangement, which differ from the requirements of US proxy solicitation or tender offer rules. However, if Regent Pacific were to elect to implement the Acquisition by means of a takeover offer, such takeover offer will be made in compliance with all applicable laws and regulations, including the relevant provisions of Section 14(e) of the US Exchange Act and Regulation 14E thereunder. Such a takeover offer would be made in the United States by Regent Pacific and no one else. In addition to any such takeover offer, Regent Pacific, certain affiliated companies and the nominees or brokers (acting as agents) may make certain purchases of, or arrangements to purchase, shares in Plethora outside such takeover offer during the period in which such takeover offer would remain open for acceptance. If such purchases or arrangements to purchase were to be made they would be made outside the United States and would comply with applicable law, including the US Exchange Act. Any information about such purchases will be disclosed as required in the UK, will be reported to a Regulatory Information Service of the UKLA and will be available on the London Stock Exchange website: www.londonstockexchange.com.

This announcement is not an offer of securities for sale in the United States and the New Regent Pacific Shares, which will be issued in connection with the Acquisition, have not been, and will not be, registered under the US Securities Act 1933 (the "US Securities Act") or under the securities law of any state, district or other jurisdiction of the United States or any Restricted Jurisdiction and no regulatory clearance in respect of the New Regent Pacific Shares has been, or will be, applied for in any jurisdiction other than the United Kingdom. Accordingly, the New Regent Pacific Shares may not be offered, sold, resold, delivered, distributed or otherwise transferred, directly or indirectly, in or into the United States absent registration under the US Securities Act or an exemption therefrom. The New Regent Pacific Shares are expected to be issued in reliance upon the exemption from the registration requirements of the US Securities Act provided by Section 3(a)(10) thereof. Plethora Shareholders (whether or not US persons) who are or will be affiliates (within the meaning of the US Securities Act) of Regent Pacific or Plethora prior to, or of Regent Pacific after, the Effective Date will be subject to certain US transfer restrictions relating to the New Regent Pacific Shares received pursuant to the Scheme.

None of the securities referred to in this announcement have been approved or disapproved by the SEC, any state securities commission in the United States or any other US regulatory authority, nor have such authorities passed upon or determined the adequacy or accuracy of the information contained in this announcement. Any representation to the contrary is a criminal offence in the United States.

Regent Pacific is organised under the laws of the Cayman Islands. Plethora is organised under the laws of England and Wales. All of the officers and directors of Regent Pacific and Plethora are residents of countries other than the United States. The significant majority of the assets of Regent Pacific and Plethora are located outside of the United States. As a result, it may not be possible to effect service of process within the United States upon Regent Pacific, Plethora, or any of their respective officers or directors, or to enforce outside the United States judgements obtained against Regent Pacific, Plethora, or any of their respective officers or directors in US courts, including, without limitation, judgements based upon the civil liability provisions of the US federal securities laws or the laws of any state or territory within the United States. It may not be possible to sue Regent Pacific or Plethora or their respective officers or directors in a non-US court for violations of US securities laws. It may be difficult to compel Regent Pacific, Plethora and their respective affiliates to subject themselves to the jurisdiction and judgment of a US court.

Warning: The contents of this announcement have not been reviewed by any regulatory authority in Hong Kong. Hong Kong holders of Plethora Shares are advised to exercise caution in relation to the Acquisition and the contents of this announcement. If a Hong Kong holder of Plethora Shares is in any doubt about any of the contents of this announcement, they should obtain independent professional advice. Please note that (i) neither this announcement nor any other document constitutes an offer or sale in Hong Kong of Regent Pacific Shares, (ii) no Regent Pacific Shares may be offered or sold in Hong Kong by means of this announcement or any other document other than to professional investors within the meaning of Part I of Schedule 1 to the Securities and Futures Ordinance of Hong Kong (Cap. 571) ("SFO") and any rules made thereunder ("professional investors"), or in other circumstances which do not result in this announcement being a "prospectus" as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance of Hong Kong (Cap. 32) ("CWUMPO") or which do not constitute an offer or invitation to the public for the purposes of the CWUMPO or the SFO, and (iii) no person shall issue or possess for the purposes of issue, whether in Hong Kong or elsewhere, any advertisement, invitation or document relating to the Regent Pacific Shares which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to those Regent Pacific Shares which are or are intended to be disposed of only to persons outside Hong Kong or only to such professional investors.

Unless otherwise determined by Regent Pacific or required by the City Code on Takeovers & Mergers (the "Takeover Code"), and permitted by applicable law and regulation, the Acquisition will not be made, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction, and the Acquisition will not be capable of acceptance from or within a Restricted Jurisdiction. Accordingly, copies of this announcement and all documents relating to the Acquisition are not being, and must not be, directly or indirectly, mailed, transmitted or otherwise forwarded, distributed or sent in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction, and persons receiving this announcement and all documents relating to the Acquisition (including custodians, nominees and trustees) must not mail or otherwise distribute or send them in, into or from such jurisdictions where to do so would violate the laws in that jurisdiction.

The availability of the Acquisition to Plethora Shareholders who are not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are resident. Persons who are not resident in the United Kingdom should inform themselves of, and observe, any applicable requirements.

The New Regent Pacific Shares may not be offered, sold or delivered, directly or indirectly, in, into or from any Restricted Jurisdiction or to, or for the account or benefit of, any Restricted Overseas Persons except pursuant to an applicable exemption from, or in a transaction not subject to, applicable securities laws of those jurisdictions.

Disclosure requirements of the Takeover Code

Under Rule 8.3(a) of the Takeover Code, any person who is interested in 1 per cent. or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3:30 p.m. (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3:30 p.m. (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Takeover Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3:30 p.m. (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Takeover Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

Publication on Website

A copy of this announcement will be made available at www.plethorasolutions.co.uk no later than 12:00 noon (London time) or 8:00 p.m. (Hong Kong time) on 8 March 2016 (being the business day following the date of this announcement). A copy of this announcement will also be made available as soon as possible at www.regentpac.com. The content of the websites referred to in this announcement is not incorporated into and does not form part of this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEADDXEDDKEFF
Date   Source Headline
18th Nov 20154:56 pmBUSForm 8.3 - Plethora Solutions Holdings Plc
18th Nov 20158:08 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
17th Nov 20159:00 amRNSForm 8 (OPD) Plethora Solutions Holdings PLC
17th Nov 20159:00 amRNSForm 8 (OPD) (Regent Pacific Group Limited)
17th Nov 20159:00 amRNSForm 8 (OPD) (Plethora Solutions Holdings plc)
17th Nov 20158:09 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
16th Nov 20158:47 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
13th Nov 20158:59 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
12th Nov 20155:26 pmRNSUpdate in relation to Letters of Intent
12th Nov 20159:03 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
11th Nov 20153:14 pmRNSForm 8.3 - AMENDMENT Plethora Solutions Holdings
11th Nov 201510:54 amRNSForm 8.3 - Plethora Solutions Holdings PLC
11th Nov 20157:41 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
10th Nov 20158:32 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
10th Nov 20158:15 amRNSLetter of Intent Signed
9th Nov 20155:10 pmRNSHolding(s) in Company
9th Nov 20152:36 pmRNSForm 8.3 - Plethora Solutions Holdings Plc
9th Nov 201511:50 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
6th Nov 20153:20 pmRNSRULE 2.10 UPDATE
6th Nov 20159:14 amRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
5th Nov 20153:53 pmRNSForm 8.3 - Plethora Solutions Holdings Plc
5th Nov 20151:14 pmRNSForm 8.5 (EPT/RI) - Plethora Solutions PLC
5th Nov 20158:27 amRNSForm 8.3 - Regent Pacific Group Ltd
4th Nov 20156:28 pmRNSRULE 2.10 UPDATE
4th Nov 20154:35 pmRNSForm 8 (DD) - Plethora Solutions Holdings plc
4th Nov 201510:03 amRNSPossible Offer for Plethora Solutions Holdings plc
28th Oct 20152:21 pmRNSDirector's Shareholding
28th Aug 20154:21 pmRNSHalf Yearly Report
11th Jun 201512:00 pmRNSResult of AGM
5th Jun 201512:16 pmRNSAgreement with Regent Pacific
12th May 20157:01 amRNSBoard Appointment
27th Apr 20154:30 pmRNSHolding(s) in Company
15th Apr 20155:05 pmRNSHolding(s) in Company
13th Apr 20158:16 amRNSHolding(s) in Company
1st Apr 20157:00 amRNSDirector Dealing and Issue of Equity
30th Mar 20151:30 pmRNSFinal Results
13th Feb 20152:33 pmRNSDirector/PDMR Dealing
9th Jan 20155:00 pmRNSTo attend J.P. Morgan's 33rd Healthcare Conference
22nd Dec 20147:00 amRNSDirector/PDMR dealing
11th Dec 20147:00 amRNSAppointment of NOMAD and Broker
11th Nov 20147:00 amRNSCompany Update
10th Nov 20147:00 amRNSRecordati Upfront Payment Received
31st Oct 20147:00 amRNSChange of Adviser
7th Oct 20147:00 amRNSPSD502 to be marketed as Fortacin in the EU
3rd Oct 201411:11 amRNSHolding(s) in Company
30th Sep 20145:38 pmRNSTotal Voting Rights
29th Sep 20142:26 pmRNSIssue of Equity
29th Sep 20147:00 amRNSUpdate regarding the European License Agreement
23rd Sep 20145:28 pmRNSHolding(s) in Company
19th Sep 20142:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.